Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about COGNITIVE IMPAIRMENT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
graph TD
COGNITIVE_IMPAIRMENT["COGNITIVE IMPAIRMENT"]
Trilobatin["Trilobatin"] -->|"treats"| COGNITIVE_IMPAIRMENT
Tmt["Tmt"] -->|"causes"| COGNITIVE_IMPAIRMENT
Ckd["Ckd"] -->|"causes"| COGNITIVE_IMPAIRMENT
Kidney_Failure["Kidney Failure"] -->|"causes"| COGNITIVE_IMPAIRMENT
Alzheimer_s_Disease["Alzheimer's Disease"] -->|"causes"| COGNITIVE_IMPAIRMENT
Rehmannioside_A["Rehmannioside A"] -->|"treats"| COGNITIVE_IMPAIRMENT
Protective_Genetic_Variants["Protective Genetic Variants"] -->|"modulates"| COGNITIVE_IMPAIRMENT
Metformin["Metformin"] -.protects against.-> COGNITIVE_IMPAIRMENT
Neuroinflammation["Neuroinflammation"] -->|"causes"| COGNITIVE_IMPAIRMENT
MNPs_FMN["MNPs@FMN"] -->|"treats"| COGNITIVE_IMPAIRMENT| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease | associated_with | disease | 0.95 |
| Alzheimer's Disease | biomarker_for | disease | 0.90 |
| Narcolepsy Type 1 | associated_with | disease | 0.90 |
| Diabetic Encephalopathy | associated_with | disease | 0.85 |
| Alzheimer Disease | associated_with | disease | 0.85 |
| PI3K/AKT PATHWAY | activates | concept | 0.50 |
| ENDOTHELIAL CELLS | inhibits | concept | 0.50 |
| PI3K/AKT SIGNALING | activates | concept | 0.50 |
| EXCITOTOXICITY | activates | concept | 0.50 |
| Neuroprotection | activates | process | 0.50 |
| Gut Microbiota | inhibits | process | 0.50 |
| CEREBROSPINAL FLUID | activates | concept | 0.50 |
| AMYLOID-β | activates | concept | 0.50 |
| Cellular Senescence | inhibits | cell_type | 0.50 |
| AMYLOID-β | inhibits | concept | 0.50 |
| CEREBROSPINAL FLUID | inhibits | concept | 0.50 |
| CX43 | inhibits | concept | 0.50 |
| PREFRONTAL CORTEX | inhibits | concept | 0.50 |
| GENE EXPRESSION | inhibits | concept | 0.50 |
| NUCLEUS | inhibits | concept | 0.50 |
| Cognitive Decline | inhibits | disease | 0.50 |
| NEUTROPHIL | inhibits | cell_type | 0.50 |
| NEUTROPHILS | inhibits | concept | 0.50 |
| MICROGLIAL ACTIVATION | activates | concept | 0.50 |
| Gut Microbiota | activates | process | 0.50 |
| CHOLESTEROL METABOLISM | inhibits | concept | 0.50 |
| MAPK SIGNALING | inhibits | concept | 0.50 |
| Proteins | inhibits | protein | 0.50 |
| WNT SIGNALING | inhibits | concept | 0.50 |
| CEREBRAL CORTEX | inhibits | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Copper | causes | compound | 0.95 |
| ALZHEIMER'S DISEASE | causes | disease | 0.95 |
| Ginsenoside Re | treats | compound | 0.95 |
| Stem Cell Therapy | treats | drug | 0.95 |
| Pterostilbene | treats | compound | 0.95 |
| Scopolamine | causes | drug | 0.95 |
| p-tau217 | correlates_with | biomarker | 0.95 |
| Tmt | causes | compound | 0.95 |
| Alzheimer's Disease | causes | disease | 0.95 |
| Kidney Failure | causes | disease | 0.95 |
| Metformin | treats | drug | 0.95 |
| Ckd | causes | disease | 0.95 |
| Ginsenoside Rk1 | treats | compound | 0.95 |
| Ginsenoside Ro | treats | compound | 0.95 |
| Trilobatin | treats | compound | 0.95 |
| Quinolinic Acid | causes | compound | 0.95 |
| Butyrate | treats | compound | 0.95 |
| Danggui-Shaoyao-San | treats | drug | 0.95 |
| Parkinson's Disease | causes | disease | 0.95 |
| BDNF | associated_with | protein | 0.95 |
| Chronic Kidney Disease | causes | disease | 0.95 |
| Parkinson Disease | causes | disease | 0.92 |
| Neuroinflammation | causes | process | 0.90 |
| MNPs@FMN | treats | drug | 0.90 |
| C3A | correlates_with | protein | 0.90 |
| Gut-Brain Axis | regulates | pathway | 0.90 |
| Neutrophil-Microglia Interactions | mediates | process | 0.90 |
| Rehmannioside A | treats | drug | 0.90 |
| Protective Genetic Variants | modulates | biomarker | 0.90 |
| TDP43 | contributes_to | entity | 0.90 |
| Protective Genetic Variants | protects_against | biomarker | 0.90 |
| APP/PS1 | causes | gene | 0.90 |
| Aging | associated_with | process | 0.90 |
| Exendin-4 | treats | drug | 0.90 |
| Tanshinone Iia | protects_against | compound | 0.90 |
| Tdp-43 Pathology | associated_with | biomarker | 0.90 |
| Metformin | protects_against | drug | 0.90 |
| SYN1 | associated_with | protein | 0.90 |
| Prefrontal Cortex | associated_with | brain_region | 0.90 |
| Glp1 Receptor Agonists | treats | drug | 0.90 |
| P-Tau217 | correlates_with | biomarker | 0.90 |
| APOE ε4 | causes | gene | 0.90 |
| AQP4 | causes | protein | 0.90 |
| TREM2 | contributes_to | gene | 0.90 |
| Gut-Brain Axis | modulates | pathway | 0.90 |
| LARS2 | associated_with | gene | 0.90 |
| Sulfatide Deficiency | causes | phenotype | 0.90 |
| Plasma GFAP | correlates_with | biomarker | 0.90 |
| Chronic REM sleep deprivation | causes | process | 0.90 |
| Millimeter waves | treats | compound | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.682
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity